Cargando…
Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database
Background: Underutilization of operative management of early stage pancreatic cancer is associated with sociodemographic variables, including age, race, facility type, insurance, and education. It is currently unclear how these variables are associated with survival in patients who undergo surgery....
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520653/ https://www.ncbi.nlm.nih.gov/pubmed/32999955 http://dx.doi.org/10.1089/pancan.2020.0011 |
_version_ | 1783587819481989120 |
---|---|
author | Watson, Michael D. Miller-Ocuin, Jennifer L. Driedger, Michael R. Beckman, Michael J. McKillop, Iain H. Baker, Erin H. Martinie, John B. Vrochides, Dionisios Iannitti, David A. Ocuin, Lee M. |
author_facet | Watson, Michael D. Miller-Ocuin, Jennifer L. Driedger, Michael R. Beckman, Michael J. McKillop, Iain H. Baker, Erin H. Martinie, John B. Vrochides, Dionisios Iannitti, David A. Ocuin, Lee M. |
author_sort | Watson, Michael D. |
collection | PubMed |
description | Background: Underutilization of operative management of early stage pancreatic cancer is associated with sociodemographic variables, including age, race, facility type, insurance, and education. It is currently unclear how these variables are associated with survival in patients who undergo surgery. Methods: Patients with clinical stage I pancreatic adenocarcinoma were identified within the National Cancer Database (2010–2016). Utilization of surgery and nonoperative management was determined. Nonclinical factors associated with nonoperative management were identified by multivariable analysis. The association between nonclinical factors and survival was assessed in patients who received operative management. Results: A total of 17,833 patients with clinical stage I pancreatic cancer were identified, and 41.2% underwent operative intervention. Approximately 46% of nonoperatively managed patients lacked a contraindication. Operatively managed patients had longer overall survival (OS) than those who were nonoperatively managed or untreated (25.1 months vs. 11.1 months vs. 5.1 months, p < 0.0001). Factors associated with nonoperative management included age, black/Hispanic race, nonacademic facilities, nonprivate health insurance, lower education level, and lower income. In operatively managed patients, nonclinical factors associated with lower OS included Medicaid (hazard ratio [HR] 1.27) and treatment at nonacademic facilities (HR 1.20–1.22). Patients on Medicaid received less adjuvant therapy and had higher 30- and 90-day mortality rates. Patients treated at nonacademic facilities received less neoadjuvant therapy, had worse pathologic outcomes, and had higher 30- and 90-day mortality rates. Conclusions: Surgical management is underutilized in clinical stage I pancreatic cancer. Primary insurance payor and facility type appear to be associated with OS in patients who undergo operative management. |
format | Online Article Text |
id | pubmed-7520653 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Mary Ann Liebert, Inc., publishers |
record_format | MEDLINE/PubMed |
spelling | pubmed-75206532020-09-29 Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database Watson, Michael D. Miller-Ocuin, Jennifer L. Driedger, Michael R. Beckman, Michael J. McKillop, Iain H. Baker, Erin H. Martinie, John B. Vrochides, Dionisios Iannitti, David A. Ocuin, Lee M. J Pancreat Cancer Original Article Background: Underutilization of operative management of early stage pancreatic cancer is associated with sociodemographic variables, including age, race, facility type, insurance, and education. It is currently unclear how these variables are associated with survival in patients who undergo surgery. Methods: Patients with clinical stage I pancreatic adenocarcinoma were identified within the National Cancer Database (2010–2016). Utilization of surgery and nonoperative management was determined. Nonclinical factors associated with nonoperative management were identified by multivariable analysis. The association between nonclinical factors and survival was assessed in patients who received operative management. Results: A total of 17,833 patients with clinical stage I pancreatic cancer were identified, and 41.2% underwent operative intervention. Approximately 46% of nonoperatively managed patients lacked a contraindication. Operatively managed patients had longer overall survival (OS) than those who were nonoperatively managed or untreated (25.1 months vs. 11.1 months vs. 5.1 months, p < 0.0001). Factors associated with nonoperative management included age, black/Hispanic race, nonacademic facilities, nonprivate health insurance, lower education level, and lower income. In operatively managed patients, nonclinical factors associated with lower OS included Medicaid (hazard ratio [HR] 1.27) and treatment at nonacademic facilities (HR 1.20–1.22). Patients on Medicaid received less adjuvant therapy and had higher 30- and 90-day mortality rates. Patients treated at nonacademic facilities received less neoadjuvant therapy, had worse pathologic outcomes, and had higher 30- and 90-day mortality rates. Conclusions: Surgical management is underutilized in clinical stage I pancreatic cancer. Primary insurance payor and facility type appear to be associated with OS in patients who undergo operative management. Mary Ann Liebert, Inc., publishers 2020-09-21 /pmc/articles/PMC7520653/ /pubmed/32999955 http://dx.doi.org/10.1089/pancan.2020.0011 Text en © Michael D. Watson et al., 2020; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Watson, Michael D. Miller-Ocuin, Jennifer L. Driedger, Michael R. Beckman, Michael J. McKillop, Iain H. Baker, Erin H. Martinie, John B. Vrochides, Dionisios Iannitti, David A. Ocuin, Lee M. Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database |
title | Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database |
title_full | Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database |
title_fullStr | Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database |
title_full_unstemmed | Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database |
title_short | Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database |
title_sort | factors associated with treatment and survival of early stage pancreatic cancer in the era of modern chemotherapy: an analysis of the national cancer database |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520653/ https://www.ncbi.nlm.nih.gov/pubmed/32999955 http://dx.doi.org/10.1089/pancan.2020.0011 |
work_keys_str_mv | AT watsonmichaeld factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT millerocuinjenniferl factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT driedgermichaelr factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT beckmanmichaelj factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT mckillopiainh factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT bakererinh factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT martiniejohnb factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT vrochidesdionisios factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT iannittidavida factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase AT ocuinleem factorsassociatedwithtreatmentandsurvivalofearlystagepancreaticcancerintheeraofmodernchemotherapyananalysisofthenationalcancerdatabase |